🇺🇸 FDA
Pipeline program

lubiprostone

07-033L

Approved small_molecule completed

Quick answer

lubiprostone for Chronic Idiopathic Constipation is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 3 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Chronic Idiopathic Constipation
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials